BioMarin Pharmaceutical Inc.
BMRN
Jodie situation report
BioMarin Pharmaceutical Inc.'s current read is isolated; its market group is not confirming.
The latest filing is mixed. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 25 directly disclosed connections are confirming.
- Revenue increased 19.9% versus the comparable filing period.
- Operating margin fell 22.3 percentage points.
- Monitor new-patient initiation trends and timing-driven order volumes for BRINEURA and VOXZOGO across regions.
Invalidation: The isolated read changes if BMRN's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind BMRN
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
Depended on by
SRPTSarepta Therapeutics, Inc.partnerMar 2, 2026 ▾
“1 to License Agreement between Sarepta Therapeutics, Inc.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 28 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
BMRN is currently a Leader in the organic co-movement group Rare Disease Biotech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for BMRN; it is not active in the latest market snapshot.